Wearable monitoring for myasthenia gravis symptoms
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You must have a diagnosis of autoimmune myasthenia gravis (MG) with moderate to severe symptoms (MGFA classes II, III, or IV).
- You must have had a positive antibody test (like AChR, MuSK, or LRP4) OR abnormal nerve-muscle tests, OR have shown improvement with MG treatments.
- You must be able to walk 10 meters (about 30 feet) on your own, with or without a walker or cane.
- You must speak and read English fluently.
- You must be able to manage daily activities like dressing and eating without help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses small wearable sensors and a smartphone app (the BioDigit MG system) to track changes in muscle strength and daily activity over time in people starting VYVGART for generalized myasthenia gravis. It aims to see if this digital tool can accurately measure how well the treatment works.
This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.
This trial is testing a new way to track your generalized myasthenia gravis (gMG) using a smartphone app and a wearable activity monitor. It’s not testing a drug – it’s about improving how doctors monitor your condition remotely, which might help you better manage your symptoms.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.